Optimizing emergency management to reduce morbidity and mortality in pediatric burn patients.

Pediatr Emerg Med Pract

Associate Professor of Pediatrics and Emergency Medicine, Ronald O. Perelman Department of Emergency Medicine at NYU Langone Health; Director of Safetyand Quality, Hassenfeld Children's Hospital, New York, NY.

Published: June 2020

Burns are a significant cause of injury-induced morbidity and mortality in pediatric patients. The spectrum of management for pediatric burn victims is vast and relies heavily on both the classification of the burn and the body systems involved. The immediate focus of management includes resuscitation and stabilization, fluid management, and pain control. Additional focus includes decreasing the risk of infection as well as improving healing and cosmetic outcomes. Discharge care and appropriate follow-up instructions need to be communicated carefully in order to avoid long-standing complications. This supplement reviews methods for accurate classification and management of the full range of burns seen in pediatric patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

morbidity mortality
8
mortality pediatric
8
pediatric burn
8
pediatric patients
8
management
5
optimizing emergency
4
emergency management
4
management reduce
4
reduce morbidity
4
pediatric
4

Similar Publications

Efficacy of lactoferrin supplementation in pediatric infections: A systematic review and meta-analysis.

Biochem Cell Biol

January 2025

Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt, Lima, Lima, Peru.

Pediatric infections account for approximately one-third of all deaths in children under 5 globally. Lactoferrin (LF) supplementation has the potential to reduce infection-related morbidity due to its antimicrobial, anti-inflammatory and immunoregulatory properties. We conducted a systematic review and meta-analysis of oral LF supplementation randomized controlled trials (RCT) in population under 18 years old.

View Article and Find Full Text PDF

COMPLICATIONS AFTER HEPATECTOMY.

Arq Bras Cir Dig

January 2025

Instituto D'Or de Pesquisa e Ensino, Digestive Surgery Program - Rio de Janeiro (RJ), Brazil.

Complete removal of metastatic disease and maintenance of an adequate liver remnant remains the only treatment option with curative intent concerning colorectal liver metastases. Surgery impacts on the long-term prognosis and complications adversely affect oncological results. The actual morbidity involving this scenario is debatable and estimated to be ranging from 15% to 50%.

View Article and Find Full Text PDF

Spatiotemporal profile of an optimal host response to virus infection in the primate central nervous system.

PLoS Pathog

January 2025

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda, Maryland, United States of America.

Viral infections of the central nervous system (CNS) are a major cause of morbidity largely due to lack of prevention and inadequate treatments. While mortality from viral CNS infections is significant, nearly two thirds of the patients survive. Thus, it is important to understand how the human CNS can successfully control virus infection and recover.

View Article and Find Full Text PDF

Changes and determinants of pneumococcal vaccine uptake in Ethiopia.

PLOS Glob Public Health

January 2025

Ohio State Global One Health Initiative, LLC, Addis Ababa, Ethiopia.

Pneumococcal pneumonia is one of the most common causes of severe pneumonia and pneumonia-related mortality globally. It ranked among the leading causes of morbidity and mortality in children under five years in Ethiopia. Vaccination reduces the burden of pneumonia and pneumococcal infections in both children and adults.

View Article and Find Full Text PDF

The Significance of Mono- and Dual-Effective Agents in the Development of New Antifungal Strategies.

Chem Biol Drug Des

January 2025

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erzincan Binali Yildirim University, Erzincan, Turkiye.

Invasive fungal infections (IFIs) pose significant challenges in clinical settings, particularly due to their high morbidity and mortality rates. The rising incidence of these infections, coupled with increasing antifungal resistance, underscores the urgent need for novel therapeutic strategies. Current antifungal drugs target the fungal cell membrane, cell wall, or intracellular components, but resistance mechanisms such as altered drug-target interactions, enhanced efflux, and adaptive cellular responses have diminished their efficacy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!